Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: report of an unusual case
Khaliqur Rahman1, Seena George, Sriyash Mangal
1Department of Hematology, Sanjay Gandhi Post Graduate Institute of medical sciences, Lucknow, India.
Insights
This case report details a rare instance of simultaneous chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) in a 57-year-old male. Diagnosis was confirmed via immunophenotyping and cytogenetics, with positive treatment response to tyrosine kinase inhibitors.
Area of Science:
- Hematology
- Oncology
- Medical Diagnostics
Background:
- Coexistence of chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) is exceptionally rare, with limited documented cases.
- Simultaneous diagnosis presents unique challenges in hematologic malignancy management.
Observation:
- A 57-year-old male patient presented with findings suggestive of both CML and CLL.
- Volume Conductivity Scatter (VCS) technology in complete blood count analysis initially indicated the dual diagnosis.
- Immunophenotyping and cytogenetic analysis confirmed the coexistence of CML and CLL.
Findings:
- The patient was initiated on a tyrosine kinase inhibitor at 400 mg daily.
- After four months of treatment, the patient showed significant clinical improvement.
- Laboratory results indicated a favorable response, with a white blood cell count of 22 × 10^9/L and 64% lymphocytes.
Implications:
- This case highlights the importance of advanced diagnostic techniques in identifying rare concurrent hematologic malignancies.
- Successful management with tyrosine kinase inhibitors suggests potential therapeutic strategies for similar rare cases.
- Further research into the pathogenesis and optimal treatment of combined CML and CLL is warranted.
Abstract:
The coexistence of chronic myeloid leukaemia(CML) and chronic lymphocytic leukemia(CLL) has been reported occasionally in literature, with only seven cases of simultaneous occurrence of these two diseases. We present here a case of 57 yr male patient where a complete blood count and differential done using volume conductivity scatter (VCS) technology suggested a diagnosis of CML with CLL. It was further confirmed by immunophneotyping and cytogenetic analysis. The patient was started on tyrosine kinase inhibitor, 400 mg once daily. Four months after the treatment, patient is doing fine with a count of 22 × 10 9 /L and 64% lymphocytes.
More Related Videos
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Differentiation of Common Myeloid Progenitor Cells
